Ferrous gluconate 300mg tablets

Страна: Великобритания

Язык: английский

Источник: MHRA (Medicines & Healthcare Products Regulatory Agency)

Купи это сейчас

Активный ингредиент:

Ferrous gluconate

Доступна с:

Bristol Laboratories Ltd

код АТС:

B03AA03

ИНН (Международная Имя):

Ferrous gluconate

дозировка:

300mg

Фармацевтическая форма:

Oral tablet

Администрация маршрут:

Oral

класс:

No Controlled Drug Status

Тип рецепта:

Valid as a prescribable product

Обзор продуктов:

BNF: 09010101

тонкая брошюра

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
FERROUS GLUCONATE 300MG TABLETS BP
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TO TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
Always take this medicine exactly as described in this leaflet or as
your doctor or pharmacist has told you.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their
signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not
listed in this leaflet. See section 4.
•
You must talk to a doctor if you do not feel better or if you feel
worse.
WHAT IS IN THIS LEAFLET
1. What Ferrous Gluconate Tablets and what it is used for
2. What you need to know before you take Ferrous Gluconate Tablets
3. How to take Ferrous Gluconate Tablets
4. Possible side effects
5. How to store Ferrous Gluconate Tablets
6. Contents of the pack and other information
1. WHAT FERROUS GLUCONATE TABLETS AND WHAT IT IS USED FOR
The name of your medicine is Ferrous Gluconate 300mg Tablets BP. The
active substance present is Ferrous
Gluconate. Ferrous Gluconate Tablets is used for the treatment and
prevention of iron deficiency.
Ferrous Gluconate is a form of iron. Iron is necessary for the
production of haemoglobin (protein in red
blood cells), which carries oxygen around the body. Iron is involved
in the formation of myoglobin, a
pigment that stores oxygen in muscles for use during exercise.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE FERROUS GLUCONATE TABLETS
DO NOT TAKE FERROUS GLUCONATE 300MG TABLETS IF YOU:
•
are allergic (hypersensitive) to Ferrous Gluconate Tablets or medicine
containing iron or any of the other
ingredients of this medicine (listed in section 6)
•
have a build-up of too much iron in the body (haemochromatosis)
•
suffer from iron storage (haemosiderosis) 
                                
                                Прочитать полный документ
                                
                            

Характеристики продукта

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ferrous Gluconate 300 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 300 mg of Ferrous Gluconate.
Excipients of known effect: Each tablet also contains 168.2 mg of
Sucrose and
2.7 mg of Liquid glucose.
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Tablet
A dark-red, smooth, polished tablet with a slight odour.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Ferrous Gluconate 300 mg Tablets is indicated for the prevention and
treatment of iron deficiency states.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY:
Adults and the elderly:
Prophylactic:
2 tablets daily.
Therapeutic:
4 to 6 tablets daily in divided doses.
Children (aged 6-l2 years):
Prophylactic: 1 or 2 tablets daily
Therapeutic: 3 tablets daily in divided doses
These tablets are best taken about one hour before meals.
METHOD OF ADMINISTRATION:
The route of administration for Ferrous Gluconate 300 mg tablets is
oral.
4.3
CONTRAINDICATIONS
•
Hypersensitivity to the active ingredient Ferrous gluconate or to any
of the
excipients listed in section 6.1.
•
Iron preparations are contra-indicated in patients with
haemochromatosis, iron
storage or absorption diseases such as and haemosiderosis or
haemoglobinuria.
•
Iron is contraindicated in patients receiving repeated blood
transfusions, or in
patients receiving parenteral iron therapy or to patients with
anaemias not
produced by iron deficiency (some conditions, such as thalassemia may
cause
excess storage of iron).
•
Alcoholism and hepatitis.
•
Iron preparations are contraindicated in active peptic ulcer, regional
enteritis
and ulcerative colitis.
•
Ferrous Gluconate Tablets should not be used in patients with anaemia
not
produced by iron deficiency unless iron deficiency is also present.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Large doses may have irritant/ corrosive effect on gastro-intestinal
mucosa
which can lead to necrosis and perforation.
Ferrous Gluconate shou
                                
                                Прочитать полный документ
                                
                            

Поиск оповещений, связанных с этим продуктом

Просмотр истории документов